IRADIMED CORPORATION Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	86.34	83.81	73.24	65.56	53.3	41.81
Revenue Growth	11.21%	14.43%	11.71%	23.00%	27.47%	31.84%
Cost of Revenue	20.84	19.49	16.89	15.4	12.02	9.76
Gross Profit	65.5	64.32	56.35	50.16	41.28	32.05
Selling, General & Admin	34.88	35.23	31.59	27.3	23.41	20.36
Research & Development	3.06	2.95	2.8	2.82	2.24	1.87
Operating Expenses	37.94	38.18	34.39	30.12	25.65	22.23
Operating Income	27.56	26.15	21.97	20.04	15.63	9.82
Interest & Investment Income	2.01	2.01	2.19	1.86	0.58	0.03
Currency Exchange Gain (Loss)	0	0	-0.04	-0.15	-0.04	-0.03
Other Non Operating Income (Expenses)	-0.02	-	0.16	-	-	-
EBT Excluding Unusual Items	29.54	28.16	24.28	21.75	16.17	9.82
Gain (Loss) on Sale of Investments	-	-	-	-	0.01	0.02
Gain (Loss) on Sale of Assets	0.2	0.2	-0	-0.01	-	-
Pretax Income	29.75	28.36	24.28	21.74	16.18	9.84
Income Tax Expense	6.69	5.88	5.04	4.55	3.35	0.51
Net Income	23.06	22.48	19.23	17.19	12.83	9.33
Net Income to Common	23.06	22.48	19.23	17.19	12.83	9.33
Net Income Growth	11.61%	16.88%	11.87%	34.02%	37.56%	581.19%
Shares Outstanding (Basic)	13	13	13	13	13	12
Shares Outstanding (Diluted)	13	13	13	13	13	13
Shares Change	0.41%	0.55%	0.48%	0.69%	0.36%	1.21%
EPS (Basic)	1.81	1.77	1.52	1.36	1.02	0.76
EPS (Diluted)	1.79	1.75	1.50	1.35	1.02	0.74
EPS Growth	11.18%	16.67%	11.11%	32.35%	37.84%	572.73%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	25.12	17.18	17.62	6.02	9.22	10.78
Free Cash Flow Per Share	1.95	1.34	1.38	0.47	0.73	0.86
Dividend Per Share	0.770	0.710	0.470	0.150	-	-
Dividend Growth	16.67%	51.06%	213.33%	-	-	-
Gross Margin	75.86%	76.75%	76.94%	76.50%	77.45%	76.65%
Operating Margin	31.91%	31.20%	29.99%	30.56%	29.32%	23.48%
Profit Margin	26.70%	26.82%	26.26%	26.22%	24.07%	22.30%
Free Cash Flow Margin	29.09%	20.50%	24.06%	9.19%	17.30%	25.77%
EBITDA	29.18	27.31	22.78	20.8	16.3	11.22
EBITDA Margin	33.80%	32.59%	31.11%	31.73%	30.58%	26.84%
D&A For EBITDA	1.63	1.17	0.82	0.77	0.67	1.41
EBIT	27.56	26.15	21.97	20.04	15.63	9.82
EBIT Margin	31.91%	31.20%	29.99%	30.56%	29.32%	23.48%
Effective Tax Rate	22.49%	20.74%	20.77%	20.91%	20.72%	5.19%

SEC Filings: 10-K · 10-Q